| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Principal Accounting Officer | Vice President, Finance | Controller
1 company
Tourangeau Greg is a Principal Accounting Officer at Fulcrum Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $96K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 8, 2025 | FULC Fulcrum Therapeutics, Inc. | Principal Accounting Officer | Sell | 498 | $5.06 | $2,519.88 | -3.4% | +28.3% | - | |
| May 7, 2024 | FULC Fulcrum Therapeutics, Inc. | Principal Accounting Officer | Sell | 236 | $7.76 | $1,831.36 | -2.0% | +12.2% | -32.8% | |
| Mar 8, 2024 | FULC Fulcrum Therapeutics, Inc. | Vice President, Finance | Sell | 4,884 | $11.72 | $57,218.50 | -29.3% | -24.5% | -71.7% | |
| May 10, 2023 | FULC Fulcrum Therapeutics, Inc. | Principal Accounting Officer | Sell | 210 | $3.31 | $695.10 | -1.3% | +23.2% | +129.4% |